Lab Publishes New Paper on Preventing Multiple Myeloma

We are pleased to announce the publication of our most recent paper titled "Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma," which is free to view here. Screening and prevention strategies have been used successfully in some solid tumor cancers, including breast, colon, and prostate. … Continue reading Lab Publishes New Paper on Preventing Multiple Myeloma

Laboratory Receives NCI Seed Grant to Study Chronic Intermittent Hypoxia!!

We are pleased to announce that we have received a one-year, $60,000 seed grant to examine the environmental and genetic determinants underlying the transition of of MGUS into multiple myeloma. MGUS is a precursor, pre-malignant condition that occurs before the development of multiple myeloma. The majority of MGUS cases are benign, but can be devastating when it … Continue reading Laboratory Receives NCI Seed Grant to Study Chronic Intermittent Hypoxia!!

New Paper Accepted in Oncotarget!

SourceMultiple myeloma is an incurable plasma cancer and the second most common blood malignancy. We have been interested in the role oxygen plays in mediating the progression of this disease and our new collaboration with the Translational Myeloma Group at the University of Iowa has yielded it’s first publication in the journal Oncotarget. We are glad … Continue reading New Paper Accepted in Oncotarget!

Professor Bates Receives Seed Grant from the American Cancer Society !

We feel fortunate to be the proud recipients of an American Cancer Society Seed Grant to continue our work investigating how obesity promotes hematological malignancy (cancer of the blood). This grant is administered through the Holden Comprehensive Cancer Center at the University of Iowa and will provide us with the resources to really take this line … Continue reading Professor Bates Receives Seed Grant from the American Cancer Society !